Navigation Links
Mindray Medical Provides Mid-Year Update on Product Development and GPO Contracts

SHENZHEN, China, July 16 /PRNewswire-Asia-FirstCall/ -- Mindray Medical International Limited (NYSE: MR, the Company), a leading developer, manufacturer and marketer of medical devices worldwide, today announced updates on new product launches and GPO relationships for the first half of 2009.

In the first half of 2009, the Company released a total of five products, including four new products in their patient monitoring and life support line and an upgrade to one of their medical imaging products. A full description of the products is provided below.

Mindray also announced today that Mindray USA, which sells the Datascope brand of patient monitors as well as a newly introduced DPM brand of patient monitors re-engineered for the North American market, has expanded its GPO contact base.

"We are very pleased with the progress we have made with our product development and GPO relationships," commented Mr. Xu Hang, Mindray's chairman and co-chief executive officer. "Earlier in the year we announced that we plan to launch seven to nine new products in 2009 and we are well on target for achieving that goal. Additionally, the DPM product line has now been added to contracts in five of the largest GPO's. This provides contracted access to this product line for over 85% of the U.S. hospitals and surgery centers. We will continue to seek to expand our distribution platforms and rapidly bring new high-quality and low-cost products to market while generating new revenue streams in an increasingly price-competitive medical device market."


    Patient Monitoring and Life Support
    -- HyLite 6700/6500 -- is a surgical light that can provide sufficient
       lighting for operations with excellent cavity-lighting capability.
    -- HyBase 6100 -- is a surgical bed that offers a full-safety guarantee,
       can suit various surgical disciplines, and provides maximum comfort and
       great convenience to end users.

Both the HyLite 6700/6500 and HyBase 6100 received SFDA and CE marks and are brand new additions to the patient monitoring and life support line, providing even more comprehensive operating room solutions for end users.

    -- Accutorr V vital signs monitor -- has received FDA approval and is the
       company's first product jointly developed by Mindray's Mahwah U.S. and
       Shenzhen China teams.  It has the ability to track vital signs by
       patient ID, a pulse waveform and a pulse strength indicator.  The
       Accutorr V offers fast, direct operations with comfort and ease and
       comes standard with a LCD display, recorder and 1200 trend memory.
    -- NetGuard Clinical Alert System -- has also received FDA approval and is
       an innovative product developed by Mindray's Mahwah U.S. team; it can
       monitor the electrical activity of patients' hearts and send automatic
       alerts to clinical staff in the event of life-threatening cardiac
       rhythms.  This ground-breaking type of wireless cardiac monitoring can
       potentially improve patient outcomes in the Emergency Department or any
       area of the hospital in which it is utilized.

    Medical Imaging
    -- DP-6900 -- is an upgraded premium portable black and white ultrasound
       system, which received CE mark, and, via advanced imaging technologies,
       brings diagnostic confidence in a variety of clinical applications.
       Together with huge image storage capacity, powerful workflow and
       comprehensive software packages, it offers end users excellent image
       quality and flexibility.

To further expand its product portfolio, Mindray expects to launch a total of seven to nine new products in 2009.

About Mindray

We are a leading developer, manufacturer and marketer of medical devices worldwide. We maintain global headquarters in Shenzhen, China, U.S. headquarters in Mahwah, New Jersey and multiple sales offices in major international markets. From our main manufacturing and engineering base in China and through our worldwide distribution network, we are able to supply internationally a broad range of products across three primary business segments, comprised of patient monitoring and life support products, in-vitro diagnostic products and medical imaging systems. For more information, please visit .

Safe Harbor Statement

This press release contains "forward-looking statements" within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995 including those related to the development, shipment, and launch of new products, and the application for and receipt of FDA, CE mark, and SFDA regulatory clearance for our products. Statements that are not historical facts, including statements about new product releases and regulatory approvals are forward- looking statements. Readers are cautioned that these forward-looking statements are only predictions and may differ materially from actual results due to a variety of factors. Forward-looking statements involve inherent risks and uncertainties. Information regarding these risks and uncertainties is included in our public documents filed with the Securities and Exchange Commission. For a discussion of some of the risks and important factors that could affect Mindray's actual results and financial condition, see "Risk Factors" in Part I, Item 3D of Mindray's Annual Report on Form 20-F for the fiscal year ended December 31, 2008 and "Operating and Financial Review and Prospects" in Part I, Item 5 of Mindray's Annual Report on Form 20-F for the fiscal year ended December 31, 2008. Mindray does not undertake any obligation to update any forward-looking statement, except as required under applicable law. All information provided in this press release is as of June 30, 2009, and Mindray undertakes no duty to update such information, except as required under applicable law.

    For investor and media inquiries please contact:

    In the U.S.:
     Evan Smith, CFA
     Tel:   +1-212-850-5606

     John Capodanno
     Tel:   +1-212-850-5705

    In China:
     Cathy Gao
     Mindray Medical International Limited
     Tel:   +86-755-2658-2518

SOURCE Mindray Medical International Limited
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Mindray to Report Second Quarter 2009 Financial Results on August 10, 2009
2. Mindray to Attend the 2009 American Association for Clinical Chemistry Conference
3. Mindray Announces First Quarter 2009 Financial Results
4. Mindray Files Annual Report on Form 20-F with U.S. Securities and Exchange Commission
5. Mindray to Report First Quarter 2009 Financial Results on May 11, 2009
6. Mindray Medical to Exhibit New Products at 61st China International Medical Equipment Fair
7. Mindray Announces Option Exchange Offer
8. Mindray to Report Fourth Quarter and Fiscal Year 2008 Financial Results on March 4, 2009
9. Mindray Medical Achieves 2008 Product Development Goals and Announces Strong Pipeline for 2009
10. Mindray Announces Preliminary 2008 Operating Results
11. Mindray Medical to Present at the 27th Annual J.P. Morgan Healthcare Conference
Post Your Comments:
(Date:11/25/2015)... ... November 25, 2015 , ... For the first time, ... Two Organizations, One Beat ” campaign. The partnership between the two groups began in ... in MAP International’s cause. , MAP International was founded in 1954 and is an ...
(Date:11/25/2015)... ... 25, 2015 , ... Dental professionals who would like to become more proficient ... attend Dr. Mark Iacobelli’s Advanced Implant Mentoring (AIM) CE course. Courses will be held ... the co-founders of Advanced Implant Mentoring (AIM), Dr. Iacobelli and Dr. D’Orazio are proud ...
(Date:11/25/2015)... (PRWEB) , ... November 25, 2015 , ... The McHenry ... a recent successful appellate decision obtained by Attorneys Francisco J. Botto and Alex C. ... v. Illinois Workers’ Compensation Comm’n, 2015 IL App (2d) 130884WC. , According to court ...
(Date:11/25/2015)... ... November 25, 2015 , ... SCOTTSDALE, AZ) - Today, ... specializing in both surgical and non-surgical treatments, announced the expansion of his private ... Plastic Surgery. , Highly trained and nationally recognized for his natural approach, ...
(Date:11/25/2015)... ... November 25, 2015 , ... In an ongoing Clinical ... Center (RMC) in Chicago, IL, UV Angel is evaluating the efficacy of its product ... intensive care units (totaling 30 beds) from May 2014 through October 2015 at a ...
Breaking Medicine News(10 mins):
(Date:11/26/2015)... and Markets ( ) has announced the addition of ... - Rise in Cardiac Disorders and Growing Awareness among People ... Boston scientific and others. ... others. --> The market is dominated by ... scientific and others. Asia ...
(Date:11/26/2015)... 26, 2015 ... "2016 Future Horizons and Growth Strategies ... Market: Supplier Shares, Country Segment Forecasts, Competitive ... offering. --> ) has ... Future Horizons and Growth Strategies in the ...
(Date:11/26/2015)... 26, 2015 ) ... Administration of High Viscosity Drugs" report to ... announced the addition of the "Self Administration ... offering. --> Research and Markets ( ... "Self Administration of High Viscosity Drugs" ...
Breaking Medicine Technology: